AU Patent

AU2013203903A1 — Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound

Assigned to Sucampo GmbH · Expires 2013-05-02 · 13y expired

What this patent protects

H:\REC\Interoven\NRPortbl\DCC\REC\5035573_i.doc-I 1/04/2013 Provided is a pharmaceutical composition comprising a 11-deoxy-prostaglandin compound represented by formula (I): R1 -A and a fatty acid ester. By mixing the compound of formula (I) and a fatty acid ester, the compound o…

USPTO Abstract

H:\REC\Interoven\NRPortbl\DCC\REC\5035573_i.doc-I 1/04/2013 Provided is a pharmaceutical composition comprising a 11-deoxy-prostaglandin compound represented by formula (I): R1 -A and a fatty acid ester. By mixing the compound of formula (I) and a fatty acid ester, the compound of formula (I) will be stabilized.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013203903A1
Jurisdiction
AU
Classification
—
Expires
2013-05-02
Drug substance claim
No
Drug product claim
No
Assignee
Sucampo GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.